These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 18930114)
1. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease. Ezquerra M; Campdelacreu J; Gaig C; Compta Y; Muñoz E; Martí MJ; Valldeoriola F; Tolosa E Neurosci Lett; 2008 Dec; 448(1):20-3. PubMed ID: 18930114 [TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. Parsian A; Racette B; Goldsmith LJ; Perlmutter JS Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377 [TBL] [Abstract][Full Text] [Related]
4. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850 [TBL] [Abstract][Full Text] [Related]
5. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease. Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000 [TBL] [Abstract][Full Text] [Related]
6. Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Pastor P; Ezquerra M; Muñoz E; Martí MJ; Blesa R; Tolosa E; Oliva R Ann Neurol; 2000 Feb; 47(2):242-5. PubMed ID: 10665497 [TBL] [Abstract][Full Text] [Related]
7. [Association between polymorphism of alpha 1-antichymotrypsin and apolipoprotein E gene and Parkinson's disease in Shanghai Hans]. Hao Y; Xie H; Xu L Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1172-5. PubMed ID: 11769703 [TBL] [Abstract][Full Text] [Related]
8. Association of tau gene polymorphism with Parkinson's disease. Zappia M; Annesi G; Nicoletti G; Serra P; Arabia G; Pugliese P; Messina D; Caracciolo M; Romeo N; Annesi F; Pasqua AA; Spadafora P; Civitelli D; Romeo N; Epifanio A; Morgante L; Quattrone A Neurol Sci; 2003 Oct; 24(3):223-4. PubMed ID: 14600827 [TBL] [Abstract][Full Text] [Related]
9. Association between tau H2 haplotype and age at onset in frontotemporal dementia. Borroni B; Yancopoulou D; Tsutsui M; Padovani A; Sawcer SJ; Hodges JR; Spillantini MG Arch Neurol; 2005 Sep; 62(9):1419-22. PubMed ID: 16157749 [TBL] [Abstract][Full Text] [Related]
10. Correlation of tau gene polymorphism with age at onset of Parkinson's disease. Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Feldman B; Chapman J; Korczyn AD Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease. Compta Y; Martí MJ; Ibarretxe-Bilbao N; Junqué C; Valldeoriola F; Muñoz E; Ezquerra M; Ríos J; Tolosa E Mov Disord; 2009 Nov; 24(15):2203-10. PubMed ID: 19795497 [TBL] [Abstract][Full Text] [Related]
13. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases. Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870 [TBL] [Abstract][Full Text] [Related]
14. [Assessment of apolipoprotein E genotype in Parkinson disease patients with and without dementia]. Jasińska-Myga B; Opala G; Ochudło S; Tustanowski J Wiad Lek; 2004; 57(1-2):20-4. PubMed ID: 15181744 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease. Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828 [TBL] [Abstract][Full Text] [Related]
16. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease. Tröster AI; Fields JA; Paolo AM; Koller WC J Neurol Sci; 2006 Oct; 248(1-2):62-7. PubMed ID: 16769085 [TBL] [Abstract][Full Text] [Related]
17. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations. Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic associations of tau and ApoE in Parkinson's disease. Papapetropoulos S; Farrer MJ; Stone JT; Milkovic NM; Ross OA; Calvo L; McQuorquodale D; Mash DC Neurosci Lett; 2007 Mar; 414(2):141-4. PubMed ID: 17204369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]